bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Data from Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
Authors: Puig Teresa , Turrado Carlos , Benhamú Bellinda , Aguilar Helena , Relat Joana , Ortega-Gutiérrez Silvia , Casals Gemma , Marrero Pedro F. , Urruticoechea Ander , Haro Diego , López-Rodríguez María Luz , Colomer Ramon
Published: April 2023

Supplementary Data from Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
Related Article from Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
Authors: Rajkumar S. Vincent
Published: April 2023

Related Article from Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
Related Article from Toward an Effective Targeted Chemotherapy for Multiple Myeloma
Authors: Polson Andrew G. , Sliwkowski Mark X.
Published: April 2023

Related Article from Toward an Effective Targeted Chemotherapy for Multiple Myeloma
Supplementary Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Authors: Yvon Eric , Del Vecchio Michele , Savoldo Barbara , Hoyos Valentina , Dutour Aurélie , Anichini Andrea , Dotti Gianpietro , Brenner Malcolm K.
Published: April 2023

Supplementary Data from Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Supplementary Data from Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
Authors: Wang Yongyi , Hanifi-Moghaddam Payman , Hanekamp Eline E. , Kloosterboer Helenius J. , Franken Patrick , Veldscholte Jos , van Doorn Helena C. , Ewing Patricia C. , Kim J. Julie , Grootegoed J. Anton , Burger Curt W. , Fodde Riccardo , Blok Leen J.
Published: April 2023

Supplementary Data from Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02
Authors: Pollack Alan , Bae Kyounghwa , Khor Li-Yan , Al-Saleem Tahseen , Hammond M. Elizabeth , Venkatesan Varagur , Byhardt Roger W. , Asbell Sucha O. , Shipley William U. , Sandler Howard M.
Published: April 2023

Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02
CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Authors: London Cheryl A. , Malpas Phyllis B. , Wood-Follis Stacey L. , Boucher Joseph F. , Rusk Anthony W. , Rosenberg Mona P. , Henry Carolyn J. , Mitchener Kathy L. , Klein Mary K. , Hintermeister John G. , Bergman Philip J. , Couto Guillermo C. , Mauldin Guy N. , Michels Gina M.
Published: April 2023

CCR Translation for the Article from Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Supplementary Data from AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Authors: Marinov Marin , Ziogas Algirdas , Pardo Olivier E. , Tan Liwen Terence , Dhillon Tony , Mauri Francesco A. , Lane Heidi A. , Lemoine Nicholas R. , Zangemeister-Wittke Uwe , Seckl Michael J. , Arcaro Alexandre
Published: April 2023

Supplementary Data from AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Supplementary Data from Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells
Authors: Iwasa Tsutomu , Okamoto Isamu , Suzuki Minoru , Hatashita Erina , Yamada Yuki , Fukuoka Masahiro , Ono Koji , Nakagawa Kazuhiko
Published: April 2023

Supplementary Data from Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells
Supplementary Table S1 from Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
Authors: Jackson Eric M. , Sievert Angela J. , Gai Xiaowu , Hakonarson Hakon , Judkins Alexander R. , Tooke Laura , Perin Juan Carlos , Xie Hongbo , Shaikh Tamim H. , Biegel Jaclyn A.
Published: April 2023

Supplementary Table S1 from Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
Supplementary Table S3 from MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Authors: Wong Queenie W-L. , Ching Arthur K-K. , Chan Anthony W-H. , Choy Kwong-Wai , To Ka-Fai , Lai Paul B-S. , Wong Nathalie
Published: April 2023

Supplementary Table S3 from MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Supplementary Table S1 from MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Authors: Wong Queenie W-L. , Ching Arthur K-K. , Chan Anthony W-H. , Choy Kwong-Wai , To Ka-Fai , Lai Paul B-S. , Wong Nathalie
Published: April 2023

Supplementary Table S1 from MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Supplementary Data from Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
Authors: O'Connor James P.B. , Carano Richard A.D. , Clamp Andrew R. , Ross Jed , Ho Calvin C.K. , Jackson Alan , Parker Geoff J.M. , Rose Chris J. , Peale Franklin V. , Friesenhahn Michel , Mitchell Claire L. , Watson Yvonne , Roberts Caleb , Hope Lynn , Cheung Sue , Reslan Hani Bou , Go Mary Ann T. , Pacheco Glenn J. , Wu Xiumin , Cao Tim C. , Ross Sarajane , Buonaccorsi Giovanni A. , Davies Karen , Hasan Jurjees , Thornton Paula , del Puerto Olivia , Ferrara Napoleone , van Bruggen Nicholas , Jayson Gordon C.
Published: April 2023

Supplementary Data from Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
Supplementary Data from SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Authors: Roth Patrick , Kissel Maria , Herrmann Caroline , Eisele Günter , Leban Johann , Weller Michael , Schmidt Friederike
Published: April 2023

Supplementary Data from SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo
Supplementary Data from MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Authors: Landi Maria Teresa , Zhao Yingdong , Rotunno Melissa , Koshiol Jill , Liu Hui , Bergen Andrew W. , Rubagotti Maurizia , Goldstein Alisa M. , Linnoila Ilona , Marincola Francesco M. , Tucker Margaret A. , Bertazzi Pier Alberto , Pesatori Angela C. , Caporaso Neil E. , McShane Lisa M. , Wang Ena
Published: April 2023

Supplementary Data from MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Supplementary Data from JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Authors: Arts Janine , King Peter , Marin Ann , Floren Wim , Belin Ann , Janssen Lut , Pilatte Isabelle , Roux Bruno , Decrane Laurence , Gilissen Ron , Hickson Ian , Vreys Veronique , Cox Eugene , Bol Kees , Talloen Willem , Goris Ilse , Andries Luc , Du Jardin Marc , Janicot Michel , Page Martin , van Emelen Kristof , Angibaud Patrick
Published: April 2023

Supplementary Data from JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Supplementary Data from Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Authors: Mom Constantijne H. , Verweij Jaap , Oldenhuis Corina N.A.M. , Gietema Jourik A. , Fox Norma Lynn , Miceli Renée , Eskens Ferry A.L.M. , Loos Walter J. , de Vries Elisabeth G.E. , Sleijfer Stefan
Published: April 2023

Supplementary Data from Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Supplementary Data from HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
Authors: Knowles Lynn M. , Stabile Laura P. , Egloff Ann Marie , Rothstein Mary E. , Thomas Sufi M. , Gubish Christopher T. , Lerner Edwina C. , Seethala Raja R. , Suzuki Shinsuke , Quesnelle Kelly M. , Morgan Sarah , Ferris Robert L. , Grandis Jennifer R. , Siegfried Jill M.
Published: April 2023

Supplementary Data from HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
Supplementary Data Figure 1 from Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors
Authors: Takahashi Yu , Akishima-Fukasawa Yuri , Kobayashi Noritoshi , Sano Tsuyoshi , Kosuge Tomoo , Nimura Yuji , Kanai Yae , Hiraoka Nobuyoshi
Published: April 2023

Supplementary Data Figure 1 from Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors
Supplementary Data from Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression
Authors: Ding Shian-ling , Yu Jyh-Cherng , Chen Shou-Tung , Hsu Giu-Cheng , Hsu Huan-Ming , Ho Jar Yi , Lin Yu Hsin , Chang Chien-Ching , Fann Cathy S.J. , Cheng Chun-Wen , Wu Pei-Ei , Shen Chen-Yang
Published: April 2023

Supplementary Figures S1-S2 and Supplementary Tables S1-S2.
Supplementary Data from Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding
Authors: Belletti Barbara , Vaidya Jayant S. , D'Andrea Sara , Entschladen Frank , Roncadin Mario , Lovat Francesca , Berton Stefania , Perin Tiziana , Candiani Ezio , Reccanello Sonia , Veronesi Andrea , Canzonieri Vincenzo , Trovò Mauro G. , Zaenker Kurt S. , Colombatti Alfonso , Baldassarre Gustavo , Massarut Samuele
Published: April 2023

Supplementary Data from Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding
Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
Authors: Davies D. Mark , de Vries Petrus J. , Johnson Simon R. , McCartney Deborah L. , Cox Jane A. , Serra Andreas L. , Watson Peter C. , Howe Christopher J. , Doyle Tim , Pointon Kate , Cross Justin J. , Tattersfield Anne E. , Kingswood J. Chris , Sampson Julian R.
Published: April 2023

Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
Supplementary Figure 1 from Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
Authors: Chang Gee-Chen , Liu Ko-Jiunn , Hsieh Chia-Ling , Hu Tsai-Shu , Charoenfuprasert Suparat , Liu Hsiung-Kun , Luh Kwen-Tay , Hsu Li-Han , Wu Chew-Wen , Ting Chou-Chik , Chen Chih-Yi , Chen Kun-Chieh , Yang Tsung-Ying , Chou Teh-Ying , Wang Wen-Hua , Whang-Peng Jacqueline , Shih Neng-Yao
Published: April 2023

Supplementary Figure 1 from Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
CCR Translation for This Article from Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer
Authors: Hyslop Terry , Weinberg David S. , Schulz Stephanie , Barkun Alan , Waldman Scott A.
Published: April 2023

CCR Translation for This Article from Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer
Supplementary Figure S1 from Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
Authors: Dowlati Afshin , Gray Robert , Sandler Alan B. , Schiller Joan H. , Johnson David H.
Published: April 2023

Supplementary Figure S1 from Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
Supplementary Figures S1-S2 from Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1
Authors: Korsisaari Nina , Ross Jed , Wu Xiumin , Kowanetz Marcin , Pal Navneet , Hall Linda , Eastham-Anderson Jeffrey , Forrest William F. , Van Bruggen Nicholas , Peale Franklin V. , Ferrara Napoleone
Published: April 2023

Supplementary Figures S1-S2 from Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1
Supplementary Table 1 from Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2
Authors: Nadiminty Nagalakshmi , Lou Wei , Lee Soo Ok , Mehraein-Ghomi Farideh , Kirk Jason S. , Conroy Jeffrey M. , Zhang Haitao , Gao Allen C.
Published: April 2023

Supplementary Table 1 from Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2
Supplementary Data from Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Authors: Alizadeh Darya , Zhang Leying , Brown Christine E. , Farrukh Omar , Jensen Michael C. , Badie Behnam
Published: April 2023

Supplementary Figure S1.
Supplement for Statistical Methods from Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy
Authors: Tonra James R. , Deevi Dhanvanthri S. , Corcoran Erik , Li Huiling , Wang Su , Carrick Francine E. , Hicklin Daniel J.
Published: April 2023

Supplement for Statistical Methods from Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy
Supplementary Data from Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma
Authors: Lam Chi-Tat , Yang Zhen-Fan , Lau Chi-Keung , Tam Ka-Ho , Fan Sheung-Tat , Poon Ronnie T.P.
Published: April 2023

Supplementary Figures S1-S4; Supplementary Tables S1-S5.
Legend for Supplementary Data from Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder
Authors: Wild Peter J. , Herr Alexander , Wissmann Christoph , Stoehr Robert , Rosenthal Andre , Zaak Dirk , Simon Ronald , Knuechel Ruth , Pilarsky Christian , Hartmann Arndt
Published: April 2023

Legend for Supplementary Data from Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder
Supplementary Data from A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas
Authors: Bax Dorine A. , Mackay Alan , Little Suzanne E. , Carvalho Diana , Viana-Pereira Marta , Tamber Narinder , Grigoriadis Anita E. , Ashworth Alan , Reis Rui M. , Ellison David W. , Al-Sarraj Safa , Hargrave Darren , Jones Chris
Published: April 2023

Supplementary Table S1.
Supplementary Data from Epidermal Growth Factor Receptor Inhibition Augments the Expression of MHC Class I and II Genes
Authors: Pollack Brian P. , Sapkota Bishu , Cartee Todd V.
Published: April 2023

Supplementary Figures S1-S8; Supplementary Materials and Methods.
Related Article from Tumor Endothelial Cells Join the Resistance
Authors: Dudley Andrew C. , Klagsbrun Michael
Published: April 2023

Related Article from Tumor Endothelial Cells Join the Resistance
Supplementary Data from Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
Authors: Laheru Dan , Lutz Eric , Burke James , Biedrzycki Barbara , Solt Sara , Onners Beth , Tartakovsky Irena , Nemunaitis John , Le Dung , Sugar Elizabeth , Hege Kristen , Jaffee Elizabeth
Published: April 2023

Supplementary Data from Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
Supplementary Figures S1-S4 from Evidence for Microtubule Target Engagement in Tumors of Patients Receiving Ixabepilone
Authors: Zhuang Sen H. , Hung Y. Elizabeth , Hung Laura , Robey Robert W. , Sackett Dan L. , Linehan W. Marston , Bates Susan E. , Fojo Tito , Poruchynsky Marianne S.
Published: April 2023

Supplementary Figures S1-S4 from Evidence for Microtubule Target Engagement in Tumors of Patients Receiving Ixabepilone
Supplementary Information and Table 1 from Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
Authors: Dolled-Filhart Marisa , Rydén Lisa , Cregger Melissa , Jirström Karin , Harigopal Malini , Camp Robert L. , Rimm David L.
Published: April 2023

Supplementary Information and Table 1 from Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
Supplementary Table 1 from Gene Expression Patterns and Profile Changes Pre- and Post-Erlotinib Treatment in Patients with Metastatic Breast Cancer
Authors: Yang Sherry X. , Simon Richard M. , Tan Antoinette R. , Nguyen Diana , Swain Sandra M.
Published: April 2023

XLS file, 29K, Table 1. Genes significantly changed after erlotinib treatment.
Supplementary Data from Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma
Authors: Woo Hyun Goo , Park Eun Sung , Cheon Jae Hee , Kim Ju Han , Lee Ju-Seog , Park Bum Joon , Kim Won , Park Su Cheol , Chung Young Jin , Kim Byeong Gwan , Yoon Jung-Hwan , Lee Hyo-Suk , Kim Chung Yong , Yi Nam-Joon , Suh Kyung-Suk , Lee Kuhn Uk , Chu In-Sun , Roskams Tania , Thorgeirsson Snorri S. , Kim Yoon Jun
Published: April 2023

Supplementary Data from Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma
Supplementary Figures S1-S6 from Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection
Authors: Soussi Thierry , Asselain Bernard , Hamroun Dalil , Kato Shunsuke , Ishioka Chikashi , Claustres Mireille , Béroud Christophe
Published: April 2023

Six Figures and Legends
Supplementary Table S1 from Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families
Authors: Argent Richard H. , Thomas Rachael J. , Aviles-Jimenez Francisco , Letley Darren P. , Limb Marie C. , El-Omar Emad M. , Atherton John C.
Published: April 2023

Supplementary Table S1 from Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families
Supplementary Table 3 from Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
Authors: Sharma Padmanee , Shen Yu , Wen Sijin , Bajorin Dean F. , Reuter Victor E. , Old Lloyd J. , Jungbluth Achim A.
Published: April 2023

Supplementary Table 3 from Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
Supplementary Figure S1 from Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy
Authors: Lerner Immanuel , Baraz Leah , Pikarsky Eli , Meirovitz Amichay , Edovitsky Evgeny , Peretz Tamar , Vlodavsky Israel , Elkin Michael
Published: April 2023

Supplementary Figure S1 from Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy
Supplementary Table S9 from Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study
Authors: Lauss Martin , Ringnér Markus , Höglund Mattias
Published: April 2023

Supplementary Table S9.
Supplementary Table S3 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Authors: Vincent-Salomon Anne , Lucchesi Carlo , Gruel Nadège , Raynal Virginie , Pierron Gaëlle , Goudefroye Rémi , Reyal Fabien , Radvanyi François , Salmon Rémy , Thiery Jean-Paul , Sastre-Garau Xavier , Sigal-Zafrani Brigitte , Fourquet Alain , Delattre Olivier
Published: April 2023

Supplementary Table S3 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Supplementary Table S2 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Authors: Vincent-Salomon Anne , Lucchesi Carlo , Gruel Nadège , Raynal Virginie , Pierron Gaëlle , Goudefroye Rémi , Reyal Fabien , Radvanyi François , Salmon Rémy , Thiery Jean-Paul , Sastre-Garau Xavier , Sigal-Zafrani Brigitte , Fourquet Alain , Delattre Olivier
Published: April 2023

Supplementary Table S2 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Supplementary Table S1 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Authors: Vincent-Salomon Anne , Lucchesi Carlo , Gruel Nadège , Raynal Virginie , Pierron Gaëlle , Goudefroye Rémi , Reyal Fabien , Radvanyi François , Salmon Rémy , Thiery Jean-Paul , Sastre-Garau Xavier , Sigal-Zafrani Brigitte , Fourquet Alain , Delattre Olivier
Published: April 2023

Supplementary Table S1 from Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Supplementary Figures 1-2 from The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
Authors: Mocellin Simone , Hoon Dave , Ambrosi Alessandro , Nitti Donato , Rossi Carlo Riccardo
Published: April 2023

Supplementary Figures 1-2 from The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
Supplementary Figure 1 from An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer
Authors: Mikhitarian Kaidi , Gillanders William E. , Almeida Jonas S. , Hebert Martin Renee , Varela Juan C. , Metcalf John S. , Cole David J. , Mitas Michael
Published: April 2023

Supplementary Figure 1 from An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer
Supplementary Figure S2 from Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Authors: Zhang Zhuohan , Yang Xiaoying , Zhang Yuan , Zeng Bin , Wang Shujing , Zhu Tianhui , Roden Richard B.S. , Chen Yongsheng , Yang Rongcun
Published: April 2023

Supplementary Figure S2 from Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Supplementary Figure Legends from Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Authors: Zhang Zhuohan , Yang Xiaoying , Zhang Yuan , Zeng Bin , Wang Shujing , Zhu Tianhui , Roden Richard B.S. , Chen Yongsheng , Yang Rongcun
Published: April 2023

Supplementary Figure Legends from Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Supplementary Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
Authors: Hammer Stefanie , Sommer Anette , Fichtner Iduna , Becker Michael , Rolff Jana , Merk Johannes , Klar Ulrich , Hoffmann Jens
Published: April 2023

Supplementary Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
Supplementary Methods 1 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Authors: Dai Wei , Teodoridis Jens M. , Zeller Constanze , Graham Janet , Hersey Jenny , Flanagan James M. , Stronach Euan , Millan David W. , Siddiqui Nadeem , Paul Jim , Brown Robert
Published: April 2023

Supplementary Methods 1 from Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Text from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Figure Legends 1-7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Figure Legends 1-7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Figure 6 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Figure 6 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Tables 1-6, Figures 1-4 from Randomized Study of Paclitaxel and Tamoxifen Deposition into Human Brain Tumors: Implications for the Treatment of Metastatic Brain Tumors
Authors: Fine Robert L. , Chen Johnson , Balmaceda Casilda , Bruce Jeffrey N. , Huang May , Desai Manisha , Sisti Michael B. , McKhann Guy M. , Goodman Robert R. , Bertino Joseph S. , Nafziger Anne N. , Fetell Michael R.
Published: April 2023

Supplementary Tables 1-6, Figures 1-4 from Randomized Study of Paclitaxel and Tamoxifen Deposition into Human Brain Tumors: Implications for the Treatment of Metastatic Brain Tumors
Supplementary Figure 2 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Authors: Okano Tetsuya , Kondo Tadashi , Fujii Kiyonaga , Nishimura Toshihide , Takano Toshimi , Ohe Yuichiro , Tsuta Koji , Matsuno Yoshihiro , Gemma Akihiko , Kato Harbumi , Kudoh Shoji , Hirohashi Setsuo
Published: April 2023

Supplementary Figure 2 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Supplementary Tables 1-3, Figure Legends 1-6 from Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families
Authors: Wong Tai W. , Lee Francis Y. , Emanuel Stuart , Fairchild Craig , Fargnoli Joseph , Fink Brian , Gavai Ashvinikumar , Hammell Amy , Henley Benjamin , Hilt Christine , Hunt John T. , Krishnan Bala , Kukral Daniel , Lewin Anne , Malone Harold , Norris Derek , Oppenheimer Simone , Vite Gregory , Yu Chiang
Published: April 2023

Supplementary Tables 1-3, Figure Legends 1-6 from Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families
Supplementary Table S3 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Authors: Varticovski Lyuba , Hollingshead Melinda G. , Robles Ana I. , Wu Xiaolin , Cherry James , Munroe David J. , Lukes Luanne , Anver Miriam R. , Carter John P. , Borgel Suzanne D. , Stotler Howard , Bonomi Carrie A. , Nunez Nomelí P. , Hursting Stephen D. , Qiao Wenhui , Deng Chuxia X. , Green Jeff E. , Hunter Kent W. , Merlino Glenn , Steeg Patricia S. , Wakefield Lalage M. , Barrett J. Carl
Published: April 2023

Supplementary Table S3 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Supplementary Table S2 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Authors: Varticovski Lyuba , Hollingshead Melinda G. , Robles Ana I. , Wu Xiaolin , Cherry James , Munroe David J. , Lukes Luanne , Anver Miriam R. , Carter John P. , Borgel Suzanne D. , Stotler Howard , Bonomi Carrie A. , Nunez Nomelí P. , Hursting Stephen D. , Qiao Wenhui , Deng Chuxia X. , Green Jeff E. , Hunter Kent W. , Merlino Glenn , Steeg Patricia S. , Wakefield Lalage M. , Barrett J. Carl
Published: April 2023

Supplementary Table S2 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
Supplementary Figure 1 from Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients
Authors: Mehra Rohit , Kumar-Sinha Chandan , Shankar Sunita , Lonigro Robert J. , Jing Xiaojun , Philips Neena E. , Siddiqui Javed , Han Bo , Cao Xuhong , Smith David C. , Shah Rajal B. , Chinnaiyan Arul M. , Pienta Kenneth J.
Published: April 2023

Supplementary Figure 1 from Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients
Supplementary Table 2 from Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Authors: De Preter Katleen , Vermeulen Joëlle , Brors Benedikt , Delattre Olivier , Eggert Angelika , Fischer Matthias , Janoueix-Lerosey Isabelle , Lavarino Cinzia , Maris John M. , Mora Jaume , Nakagawara Akira , Oberthuer André , Ohira Miki , Schleiermacher Gudrun , Schramm Alexander , Schulte Johannes H. , Wang Qun , Westermann Frank , Speleman Frank , Vandesompele Jo
Published: April 2023

Supplementary Table 2 from Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Supplementary Table 1 from High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis
Authors: Srivastava Alok , Fuchs Bruno , Zhang Kunbo , Ruan Ming , Halder Chandralekha , Mahlum Eric , Weber Kristin , Bolander Mark E. , Sarkar Gobinda
Published: April 2023

Supplementary Table 1 from High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis
Supplementary Table 1 from Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease
Authors: Zecevic Alma , Sampath Deepa , Ewald Brett , Chen Rong , Wierda William , Plunkett William
Published: April 2023

Supplementary Table 1 from Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease
Supplementary Data from Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice
Authors: Fini Lucia , Piazzi Giulia , Ceccarelli Claudio , Daoud Yahya , Belluzzi Andrea , Munarini Alessandra , Graziani Giulia , Fogliano Vincenzo , Selgrad Michael , Garcia Melissa , Gasbarrini Antonio , Genta Robert M. , Boland C. Richard , Ricciardiello Luigi
Published: April 2023

Supplementary Figures S1-S3 and Supplementary Tables S1-S3.
Supplemental Figure Legends from Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
Authors: Naito Sei , Bilim Vladimir , Yuuki Kaori , Ugolkov Andrey , Motoyama Teiichi , Nagaoka Akira , Kato Tomoyuki , Tomita Yoshihiko
Published: April 2023

Supplemental Figure Legends
Related Article from How to Train Your Biomarker
Authors: Yee Douglas
Published: April 2023

Related Article from How to Train Your Biomarker
Supplementary Data from Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients
Authors: Sorrentino Carlo , Musiani Piero , Pompa Paolo , Cipollone Giuseppe , Di Carlo Emma
Published: April 2023

Supplementary Data from Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients
Supplementary Data from Diminished Sensitivity of Chronic Lymphocytic Leukemia Cells to ABT-737 and ABT-263 Due to Albumin Binding in Blood
Authors: Vogler Meike , Furdas Silviya D. , Jung Manfred , Kuwana Tomomi , Dyer Martin J.S. , Cohen Gerald M.
Published: April 2023

Supplementary Figure S1.
Supplementary Figures S1-S3 from Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma
Authors: Diamandis Eleftherios P. , Goodglick Lee , Planque Chris , Thornquist Mark D.
Published: April 2023

Supplementary Figures S1-S3.
Supplementary Data from Rapid Diagnosis of Medulloblastoma Molecular Subgroups
Authors: Schwalbe Ed C. , Lindsey Janet C. , Straughton Debbie , Hogg Twala L. , Cole Michael , Megahed Hisham , Ryan Sarra L. , Lusher Meryl E. , Taylor Michael D. , Gilbertson Richard J. , Ellison David W. , Bailey Simon , Clifford Steven C.
Published: April 2023

Supplementary Figures S1-S2; Supplementary Tables S1-S7.
Supplementary Data from A Combination of Serum Markers for the Early Detection of Colorectal Cancer
Authors: Wild Norbert , Andres Herbert , Rollinger Wolfgang , Krause Friedemann , Dilba Peter , Tacke Michael , Karl Johann
Published: April 2023

Supplementary Figure S1; Supplementary Table S1.
Supplementary Figure 1 from Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
Authors: Klebanoff Christopher A. , Gattinoni Luca , Palmer Douglas C. , Muranski Pawel , Ji Yun , Hinrichs Christian S. , Borman Zachary A. , Kerkar Sid P. , Scott Christopher D. , Finkelstein Steven E. , Rosenberg Steven A. , Restifo Nicholas P.
Published: April 2023

PDF file - 51K
Supplementary Tables from A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
Authors: Herbst Roy S. , Kurzrock Razelle , Hong David S. , Valdivieso Manuel , Hsu Cheng-Pang , Goyal Lovely , Juan Gloria , Hwang Yuying C. , Wong Susan , Hill John S. , Friberg Greg , LoRusso Patricia M.
Published: April 2023

Supplementary Table 1. Adverse events at least possibly related to conatumumab treatment* Supplementary Table 2. Noncompartmental conatumumab pharmacokinetic parameters
Supplementary Methods and Materials from A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
Authors: Herbst Roy S. , Kurzrock Razelle , Hong David S. , Valdivieso Manuel , Hsu Cheng-Pang , Goyal Lovely , Juan Gloria , Hwang Yuying C. , Wong Susan , Hill John S. , Friberg Greg , LoRusso Patricia M.
Published: April 2023

Supplementary Methods and Materials
Supplementary Data from Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
Authors: Kinders Robert J. , Hollingshead Melinda , Lawrence Scott , Ji Jiuping , Tabb Brian , Bonner William M. , Pommier Yves , Rubinstein Larry , Evrard Yvonne A. , Parchment Ralph E. , Tomaszewski Joseph , Doroshow James H.
Published: April 2023

Supplementary Figures S1-S6; Supplementary Data; Supplementary Tables S1-S3.
Supplementary Data from DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma
Authors: Minami Kahori , Chano Tokuhiro , Kawakami Takahiro , Ushida Hiroshi , Kushima Ryoji , Okabe Hidetoshi , Okada Yusaku , Okamoto Keisei
Published: April 2023

Supplementary Data from DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma
CCR Translation for This Article from Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Authors: Graves Edward E. , Vilalta Marta , Cecic Ivana K. , Erler Janine T. , Tran Phuoc T. , Felsher Dean , Sayles Leanne , Sweet-Cordero Alejandro , Le Quynh-Thu , Giaccia Amato J.
Published: April 2023

CCR Translation for This Article from Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Supplementary Data from Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Authors: Stathis Anastasios , Hotte Sebastien J. , Chen Eric X. , Hirte Holger W. , Oza Amit M. , Moretto Patricia , Webster Sheila , Laughlin Anne , Stayner Lee-Anne , McGill Shauna , Wang Lisa , Zhang Wen-jiang , Espinoza-Delgado Igor , Holleran Julianne L. , Egorin Merrill J. , Siu Lillian L.
Published: April 2023

Supplementary Figure S1.
Supplementary Figure Legends 1-6 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
Authors: Bridges Kathleen A. , Hirai Hiroshi , Buser Carolyn A. , Brooks Colin , Liu Huifeng , Buchholz Thomas A. , Molkentine Jessica M. , Mason Kathryn A. , Meyn Raymond E.
Published: April 2023

PDF file - 76K
Supplementary Table S2 from Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Authors: Konecny Gottfried E. , Winterhoff Boris , Kolarova Teodora , Qi Jingwei , Manivong Kanthinh , Dering Judy , Yang Guorong , Chalukya Meenal , Wang He-Jing , Anderson Lee , Kalli Kimberly R. , Finn Richard S. , Ginther Charles , Jones Siân , Velculescu Victor E. , Riehle Darren , Cliby William A. , Randolph Sophia , Koehler Maria , Hartmann Lynn C. , Slamon Dennis J.
Published: April 2023

Supplementary Table S2.
Supplementary Figure 3 from MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
Authors: Bridges Kathleen A. , Hirai Hiroshi , Buser Carolyn A. , Brooks Colin , Liu Huifeng , Buchholz Thomas A. , Molkentine Jessica M. , Mason Kathryn A. , Meyn Raymond E.
Published: April 2023

PDF file - 237K
Supplementary Data from Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
Authors: Sikora Andrew G. , Gelbard Alexander , Davies Michael A. , Sano Daisuke , Ekmekcioglu Suhendan , Kwon John , Hailemichael Yared , Jayaraman Padmini , Myers Jeffrey N. , Grimm Elizabeth A. , Overwijk Willem W.
Published: April 2023

Supplementary Data from Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
Supplementary Methods from Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC
Authors: Friboulet Luc , Barrios-Gonzales Daniel , Commo Frédéric , Olaussen Ken André , Vagner Stephan , Adam Julien , Goubar Aïcha , Dorvault Nicolas , Lazar Vladimir , Job Bastien , Besse Benjamin , Validire Pierre , Girard Philippe , Lacroix Ludovic , Hasmats Johanna , Dufour Fabienne , André Fabrice , Soria Jean-Charles
Published: April 2023

PDF file - 81K
Supplementary Data from Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
Authors: Mitsui Jun , Nishikawa Hiroyoshi , Muraoka Daisuke , Wang Linan , Noguchi Takuro , Sato Eiichi , Kondo Satoshi , Allison James P. , Sakaguchi Shimon , Old Lloyd J. , Kato Takuma , Shiku Hiroshi
Published: April 2023

Supplementary Data from Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
Supplementary Figures 1-5 from Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
Authors: von Baumgarten Louisa , Brucker David , Tirniceru Anca , Kienast Yvonne , Grau Stefan , Burgold Steffen , Herms Jochen , Winkler Frank
Published: April 2023

PDF file - 330K
Supplementary Figure 1A-B from Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
Authors: Linden Hannah M. , Kurland Brenda F. , Peterson Lanell M. , Schubert Erin K. , Gralow Julie R. , Specht Jennifer M. , Ellis Georgiana K. , Lawton Thomas J. , Livingston Robert B. , Petra Philip H. , Link Jeanne M. , Krohn Kenneth A. , Mankoff David A.
Published: April 2023

PDF file - 85K
Supplementary Data from DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
Authors: Alexander Brian M. , Sprott Kam , Farrow D. Allan , Wang XiaoZhe , D'Andrea Alan D. , Schnitt Stuart J. , Collins Laura C. , Weaver David T. , Garber Judy E.
Published: April 2023

Supplementary Figures S1-S2 and Supplementary Tables S1-S7.
Supplementary Table S2 from BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Authors: Hawkins Cynthia , Walker Erin , Mohamed Nequesha , Zhang Cindy , Jacob Karine , Shirinian Margret , Alon Noa , Kahn Daniel , Fried Iris , Scheinemann Katrin , Tsangaris Elena , Dirks Peter , Tressler Robert , Bouffet Eric , Jabado Nada , Tabori Uri
Published: April 2023

Supplementary Table S2 from BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Adobe PDF - Supplementary_Data.pdf from Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome
Authors: Dickens Nicholas J. , Walker Brian A. , Leone Paola E. , Johnson David C. , Brito José L. , Zeisig Athanasia , Jenner Matthew W. , Boyd Kevin D. , Gonzalez David , Gregory Walter M. , Ross Fiona M. , Davies Faith E. , Morgan Gareth J.
Published: April 2023

Adobe PDF - Supplementary_Data.pdf from Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome
Supplementary Data from The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma
Authors: Cho Daniel C. , Cohen Matthew B. , Panka David J. , Collins Michael , Ghebremichael Musie , Atkins Michael B. , Signoretti Sabina , Mier James W.
Published: April 2023

Supplementary Figure S1.
Related Article from Targeting the Tumor Microenvironment With Src Kinase Inhibition
Authors: Chung Alicia S. , Ferrara Napoleone
Published: April 2023

Related Article from Targeting the Tumor Microenvironment With Src Kinase Inhibition
Supplementary Figure 1 from Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era
Authors: Cassier Philippe A. , Fumagalli Elena , Rutkowski Piotr , Schöffski Patrick , Van Glabbeke Martine , Debiec-Rychter Maria , Emile Jean-François , Duffaud Florence , Martin-Broto Javier , Landi Bruno , Adenis Antoine , Bertucci François , Bompas Emmanuelle , Bouché Olivier , Leyvraz Serge , Judson Ian , Verweij Jaap , Casali Paolo , Blay Jean-Yves , Hohenberger Peter
Published: April 2023

PDF file, 36KB, Progression-free survival of patients with advanced PDGFRA-mutant GIST on imatinib according to the type of PDGFRA mutation.
Related Article from Fluorescence Resonance Energy Transfer Biosensors for Cancer Detection and Evaluation of Drug Efficacy
Authors: Lu Shaoying , Wang Yingxiao
Published: April 2023

Related Article from Fluorescence Resonance Energy Transfer Biosensors for Cancer Detection and Evaluation of Drug Efficacy
Supplementary Data from Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
Authors: Talbot Denis C. , Ranson Malcolm , Davies Joanna , Lahn Michael , Callies Sophie , André Valérie , Kadam Sunil , Burgess Michael , Slapak Christopher , Olsen Anna L , McHugh Peter J. , de Bono Johann S. , Matthews Julian , Saleem Azeem , Price Patricia
Published: April 2023

Supplementary Figures S1-S2.
Supplementary Data from Smac Modulates Chemosensitivity in Head and Neck Cancer Cells through the Mitochondrial Apoptotic Pathway
Authors: Sun Quanhong , Zheng Xingnan , Zhang Lin , Yu Jian
Published: April 2023

Supplementary Figures S1-S7; Supplementary Methods.
Supplementary Figures S1-S3 from Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
Authors: Romano Emanuela , Rossi Marco , Ratzinger Gudrun , de Cos Maria-Angeles , Chung David J. , Panageas Katherine S. , Wolchock Jedd D. , Houghton Alan N. , Chapman Paul B. , Heller Glenn , Yuan Jianda , Young James W.
Published: April 2023

Supplementary Figures S1-S3.
Supplementary Table S6 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Authors: Parris Toshima Z. , Danielsson Anna , Nemes Szilárd , Kovács Anikó , Delle Ulla , Fallenius Ghita , Möllerström Elin , Karlsson Per , Helou Khalil
Published: April 2023

Supplementary Table S6 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Supplementary Table S1 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Authors: Parris Toshima Z. , Danielsson Anna , Nemes Szilárd , Kovács Anikó , Delle Ulla , Fallenius Ghita , Möllerström Elin , Karlsson Per , Helou Khalil
Published: April 2023

Supplementary Table S1 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Supplementary Table S1 from The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
Authors: Koos Björn , Bender Sebastian , Witt Hendrik , Mertsch Sonja , Felsberg Jörg , Beschorner Rudi , Korshunov Andrey , Riesmeier Barbara , Pfister Stefan , Paulus Werner , Hasselblatt Martin
Published: April 2023

Supplementary Table S1 from The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
Supplementary Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Authors: Rosenberg Steven A. , Yang James C. , Sherry Richard M. , Kammula Udai S. , Hughes Marybeth S. , Phan Giao Q. , Citrin Deborah E. , Restifo Nicholas P. , Robbins Paul F. , Wunderlich John R. , Morton Kathleen E. , Laurencot Carolyn M. , Steinberg Seth M. , White Donald E. , Dudley Mark E.
Published: April 2023

Supplementary Figures S1-S2; Supplementary Tables S1-S2.
Supplementary Table 3 from Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
Authors: O'Brien Katie M. , Cole Stephen R. , Tse Chiu-Kit , Perou Charles M. , Carey Lisa A. , Foulkes William D. , Dressler Lynn G. , Geradts Joseph , Millikan Robert C.
Published: April 2023

PDF file - 12K